[1] Chen HL, Feng WC.Retrospective analysis of literature salviae miltiorrhizae and ligustrazine hydrochloride injection adverse reaction cases[J]. Journal of Modern Food and Pharmaceuticals(今日药学), 2014, 24(8): 607-609. [2] Huang ZB.Analysis of 50 cases of adverse reactions of salviae miltiorrhizae and ligustrazine injection[J]. Journal of Today Health(今日健康), 2016, 15(7): 329. [3] Zhang YR, Wu YY, Liu J, et al.analysis of 52 cases of adverse reaction of salviae miltiorrhizae and ligustrazine injection[J]. Clinical Journal of Medical Officers(临床军医杂志), 2014, 42(11): 1204-1205. [4] Yi AL.One case of allergic reaction caused by Salviae Miltiorrhizae and ligustrazine injection[J]. Herald of Medicine(医药导报), 2017, 36(9): 1061-1062. [5] Zhu YF.One case of anaphylactic shock caused by Salviae Miltiorrhizae and ligustrazine injection[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2015, 8(7A): 22-23. [6] Pan X, He J, Zhang J.One case of allergic shock caused by Danshen Chuanxiongqin injection[J]. Drug Evaluation(药品评价), 2014, 11(4): 43-44. [7] Huang HP, Huang HM.One case of anaphylactic shock caused by Salviae Miltiorrhizae and ligustrazine injection[J]. China Pharmacist(中国药师), 2015, 18(4): 630-631. [8] Liu QH, Li SJ.Progress in clinical application of Danshen Chuanxiongqin and study of adverse drug reaction[J]. Journal of North Pharmacy(北方药学), 2012, 9(9): 48-49. [9] Yuan A, Xu J, Liu YN.Contraindications between Danshen Chuanxiongqin injection and Tanreqing injection[J]. Today Nurse(当代护士), 2016, 10: 176. [10] Zhou JP.A case report of contraindications between Danshen Chuanxiongqin and breviscapine[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2012, 5(9C): 3. [11] Han XY.Contraindications between Danshen Chuanxiongqin injection and Furosemide[J]. Shanxi Medical Journal(山西医药杂志), 2011, 40(9): 939. [12] Zhang L, Chen XY.Contraindications between levofloxacin hydrochloride and injection prepared by traditional Chinese medicine[J]. China Medical Herald(中国医药导报), 2006, 23(3): 48. [13] Li XF.Contraindication between lipoic acid injection and Danshen Chuanxiongqin injection[J]. Journal of Modern Nursing(中华现代护理杂志), 2015, 21(5): 598. [14] Tao SY.Contraindication between Danshen Chuanxiongqin and Yanhuning[J]. Chinese Journal of Practical Nursing(中国实用护理杂志), 2013, 29(11): 50. [15] Wu L, Li M, Geng C, et al.Analysis of 1348 ADR/ADE cases caused by Danshen injection[J]. Journal of China Prescription Drug(中国处方药), 2015, 13(12): 1-4. [16] Jin J, Jin ZG, Xiao ZG, et al.Analysis of 153 cases of adverse drug reaction caused by Salvia Miltiorrhiza[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2010, 7(6): 370-372. [17] Sun HM.Analysis of adverse reactions of Salvia Miltiorrhiza injection in 349 cases[J]. China Health Care & Nutrition(中国保健营养), 2018, 28(12): 189. [18] Gui L, Liu J, Zhang CL, et al.Analysis on 561 cases of clinical adverse drug reaction/event caused by Danshen injection[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2017, 26(8): 547-564. [19] Wang TZ, Huang P.Adverse drug reaction caused by Ligustrazine Hydrochloride for injection:an analysis of 506 cases[J]. Anhui Medical and Pharmaceutical Journal(安徽医药), 2015, 19(3): 610-612. [20] Liu H, Chen XN, Sun D, et al.Analysis of 23 cases of adverse drug reactioninduced by Ligustrazine hydrochloride for injection[J]. Journal of Pharmaceutical Research(药学研究), 2013, 32(6): 367-369. [21] NMPA. Announcement of NMPA on revising the label for Danshen injection(No.34,2018) [EB/OL]. (2018-06-12)[2020-05-28]. http://www.nmpa.gov.cn/WS04/CL2115/228343.html. [22] Hu CQ, Xu MZ, Ma Y, et al.Determination of the allergic impurities in the parenteral injection of Chinese traditional medicines containing Salviamiltiorrhiza[J]. Acta Pharmaceutica Sinica(药学学报), 2008, 43(5): 518-522. [23] Gao Y.Summary of adverse reactions of ligustrazine[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2008, 17(18): 2901-2903. [24] Notice on the issuance of the first batch of national key monitoring and rational use drugs (chemical drugs and biological products)(No.558,2019,NHC office)[EB/OL]. (2019-07-01)[2020-5-28]. http://www.nhc.gov.cn/yzygj/s7659/201907/d356ce8a4ba1461ca66c544724dffc5e.shtml. [25] NMPA. Announcement of NMPA on revising the label for salviae miltiorrhizae and ligustrazine injection(No.71,2019)[EB/OL].(2019-09-03)[2020-05-28]. http://www.nmpa.gov.cn/WS04/CL2115/357912.htm. |